Retrospective Study
Copyright ©The Author(s) 2016.
World J Hepatol. Jul 18, 2016; 8(20): 844-849
Published online Jul 18, 2016. doi: 10.4254/wjh.v8.i20.844
Figure 1
Figure 1 The cumulative success rate of aluminum potassium sulfate and tannic acid sclerotherapy. At one year, three years and five years after ALTA sclerotherapy, the cumulative success rate of Grades II and III were 95.9% and 93.1%; 89.3% and 83.7%; and 89.3% and 78.2%, respectively. ALTA: Aluminum potassium sulfate and tannic acid.